Judith E Soberman MD MHA, FACC, FHRS, CCDS
Cardiac Electrophysiology, Heart Failure & Transplantation, Non-Invasive Cardiology, Preventive Cardiology
Professor of Medicine, UT Health Science Center - Memphis Chief Medical Officer, Paradox Pharmaceuticals, Inc
Join to view full profile
1910 Nonconnah BlvdSte 120Memphis, TN 38132
Phone+1 901-448-2300
Fax+1 901-448-6657
Dr. Soberman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MemphisMHA, Healthcare Administration, Honors, 2005 - 2009
Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 1985 - 1988
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1982 - 1985
University of Pittsburgh School of MedicineClass of 1982
Certifications & Licensure
TN State Medical License 1988 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow Heart Rhythm Society, 2009
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsPivarubicin Is More Effective Than Doxorubicin Against Triple-Negative Breast Cancer In Vivo.Leonard Lothstein, Judith Soberman, Deanna Parke, Jatin S. Gandhi, Trevor W. Sweatman
Oncology Research. 2020-12-10 - 24 citationsPartial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) TrialHollie A. Raynor, Andrea Anderson, Gary D. Miller, Rebecca Reeves, Linda M. Delahanty
Journal of the Academy of Nutrition and Dietetics. 2015-05-01 - 103 citationsEvaluation of early weight loss thresholds for identifying nonresponders to an intensive lifestyle intervention.Jessica L. Unick, Patricia E. Hogan, Rebecca H. Neiberg, Lawrence J. Cheskin, Gareth R. Dutton
Obesity. 2014-07-01
Professional Memberships
- Member
Industry Relationships
- Chief Medical Officer, Paradox Pharmaceuticals, IncParadox is a start up pharmaceutical company that endeavors to develop unique oncologic agents that are non-cardiotoxic.2010 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
